Alto Neuroscience, Inc. (ANRO) Stock Analysis

Alto Neuroscience, Inc. (ANRO) is a publicly traded company in the HEALTHCARE sector. It trades at $18.65, carries a market capitalization of $694.86M. This page summarizes the public market data, fundamentals, and frequently asked questions for ANRO, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NYSE

Key Metrics

• Price: $18.65
• Market Cap: $694.86M
• EPS: $-2.43
• 52-Week High: $28.44
• 52-Week Low: $2.15

Market Sentiment

Alto Neuroscience, Inc. currently has a Bullish sentiment score of 0.31.

About Alto Neuroscience, Inc.

Alto Neuroscience, Inc. (ANRO) is a clinical-stage biopharmaceutical company dedicated to revolutionizing mental health care through the development of innovative therapies for psychiatric disorders. Based in Los Altos, California, the company leverages advanced neurobiological research to address unmet medical needs, showcasing a robust pipeline of proprietary drug candidates. With a strong commitment to scientific excellence, Alto Neuroscience is poised to lead the next generation of psychi...

GNG Research Analysis

GNG Research scores Alto Neuroscience, Inc. (ANRO) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for ANRO.

Frequently Asked Questions

Does ANRO pay dividends?

Alto Neuroscience, Inc. (ANRO) does not currently pay a regular dividend.

What is ANRO's market cap?

Alto Neuroscience, Inc. (ANRO) has a market capitalization of $694.86M with a current stock price of $18.65.